{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:05:06Z","timestamp":1768881906821,"version":"3.49.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T00:00:00Z","timestamp":1336089600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0036423","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T22:39:19Z","timestamp":1336171159000},"page":"e36423","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["A Novel Solid-Phase Site-Specific PEGylation Enhances the In Vitro and In Vivo Biostabilty of Recombinant Human Keratinocyte Growth Factor 1"],"prefix":"10.1371","volume":"7","author":[{"given":"Zhifeng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanchuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaohui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariush","family":"Ilghari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,5,4]]},"reference":[{"key":"ref1","first-page":"3199","article-title":"Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts.","volume":"9","author":"M Brauchle","year":"1994","journal-title":"Oncogene"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1172\/JCI118250","article-title":"Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats.","volume":"96","author":"RJ Panos","year":"1995","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1073\/pnas.86.3.802","article-title":"Purification and characterization of a newly identified growth factor specific for epithelial cells.","volume":"86","author":"JS Rubin","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/1523-1747.ep12358892","article-title":"Keratinocyte growth factor (FGF-7) stimulates migration and plasminogen activator activity of normal human keratinocytes.","volume":"101","author":"R Tsuboi","year":"1993","journal-title":"J Invest Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.89.1.246","article-title":"Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.","volume":"89","author":"T Miki","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.1846048","article-title":"Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop.","volume":"251","author":"T Miki","year":"1991","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1074\/jbc.M606878200","article-title":"Keratinocyte growth factor\/fibroblast growth factor-7-regulated cell migration and invasion through activation of NF-kappaB transcription factors.","volume":"282","author":"J Niu","year":"2007","journal-title":"J Biol Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers.","volume":"351","author":"R Spielberger","year":"2004","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/annonc\/mdl332","article-title":"Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis.","volume":"18","author":"N Blijlevens","year":"2007","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/js9504393","article-title":"Stabilization of recombinant human keratinocyte growth factor by osmolytes and salts.","volume":"85","author":"BL Chen","year":"1996","journal-title":"J Pharm Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jps.2600831204","article-title":"Strategies to suppress aggregation of recombinant keratinocyte growth factor during liquid formulation development.","volume":"83","author":"BL Chen","year":"1994","journal-title":"J Pharm Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1023\/A:1018905720139","article-title":"Aggregation pathway of recombinant human keratinocyte growth factor and its stabilization.","volume":"11","author":"BL Chen","year":"1994","journal-title":"Pharm Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.","volume":"122","author":"T Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0958-1669(99)80059-7","article-title":"Chemical modification of enzymes for enhanced functionality.","volume":"10","author":"G DeSantis","year":"1999","journal-title":"Curr Opin Biotechnol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/bc9005706","article-title":"Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues.","volume":"21","author":"J Hu","year":"2010","journal-title":"Bioconjug Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00280-007-0594-5","article-title":"Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma.","volume":"62","author":"S George","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1872-034X.2011.00879.x","article-title":"Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation.","volume":"41","author":"H Tamai","year":"2011","journal-title":"Hepatol Res"},{"key":"ref18","first-page":"6953","article-title":"Separation of exenatide analogue mono-PEGylated with 40 kDA polyethylene glycol by cation exchange chromatography.","volume":"1218","author":"Y Cai","year":"2011","journal-title":"J Chromatogr A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1021\/bc060245m","article-title":"Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity.","volume":"18","author":"BK Lee","year":"2007","journal-title":"Bioconjug Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e20669","DOI":"10.1371\/journal.pone.0020669","article-title":"A better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycol.","volume":"6","author":"Z Huang","year":"2011","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/bc800063k","article-title":"Increasing solubility of proteins and peptides by site-specific modification with betaine.","volume":"19","author":"J Xiao","year":"2008","journal-title":"Bioconjug Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/protein\/gzj013","article-title":"Enhanced stability of recombinant keratinocyte growth factor by mutagenesis.","volume":"19","author":"E Hsu","year":"2006","journal-title":"Protein Eng Des Sel"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0169-409X(03)00108-X","article-title":"Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates.","volume":"55","author":"P Caliceti","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0021-9673(95)00102-S","article-title":"Purification of recombinant human basic fibroblast growth factor: stability of selective sorbents under cleaning in place conditions.","volume":"711","author":"FB Anspach","year":"1995","journal-title":"J Chromatogr A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/978-1-59745-194-9_30","article-title":"KGF-1 for wound healing in animal models.","volume":"423","author":"GP Marti","year":"2008","journal-title":"Methods Mol Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1517\/14656566.7.16.2287","article-title":"Palifermin: a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignancies.","volume":"7","author":"AW Beaven","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nbt812","article-title":"Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity.","volume":"21","author":"Y Yamamoto","year":"2003","journal-title":"Nat Biotechnol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/bit.21181","article-title":"Selective modification of surface-exposed thiol groups in Trigonopsis variabilis D-amino acid oxidase using poly(ethylene glycol) maleimide and its effect on activity and stability of the enzyme.","volume":"96","author":"A Slavica","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"ref29","first-page":"403","article-title":"Role of pharmacokinetics and metabolism in drug discovery and development.","volume":"49","author":"JH Lin","year":"1997","journal-title":"Pharmacol Rev"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1023\/A:1023402123119","article-title":"N-terminal site-specific mono-PEGylation of epidermal growth factor.","volume":"20","author":"H Lee","year":"2003","journal-title":"Pharm Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1073\/pnas.140210597","article-title":"Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity.","volume":"97","author":"Y Tsutsumi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0958-1669(96)80119-4","article-title":"The role of protein-solvent interactions in protein unfolding.","volume":"7","author":"CA Schiffer","year":"1996","journal-title":"Curr Opin Biotechnol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/bc050355d","article-title":"Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin.","volume":"17","author":"Y Nie","year":"2006","journal-title":"Bioconjug Chem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1021\/bc050322y","article-title":"Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.","volume":"17","author":"A Basu","year":"2006","journal-title":"Bioconjug Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jbiotec.2009.05.004","article-title":"Chemical modification of recombinant human keratinocyte growth factor 2 with polyethylene glycol improves biostability and reduces animal immunogenicity.","volume":"142","author":"Z Huang","year":"2009","journal-title":"J Biotechnol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e1176","DOI":"10.1371\/journal.pone.0001176","article-title":"Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key.","volume":"2","author":"U Das","year":"2007","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1016\/S0021-9258(17)37331-3","article-title":"Pseudomonas exotoxin A mutants. Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner.","volume":"269","author":"CT Kuan","year":"1994","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1126\/science.284.5422.1998","article-title":"Initiation of mammalian liver development from endoderm by fibroblast growth factors.","volume":"284","author":"J Jung","year":"1999","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/hep.21814","article-title":"Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation.","volume":"46","author":"T Berg","year":"2007","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1038\/sj.onc.1206499","article-title":"Fibroblast growth factor receptor signalling is crucial for liver homeostasis and regeneration.","volume":"22","author":"H Steiling","year":"2003","journal-title":"Oncogene"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1096\/fj.09-131730","article-title":"Compensatory growth mechanisms regulated by BMP and FGF signaling mediate liver regeneration in zebrafish after partial hepatectomy.","volume":"23","author":"NG Kan","year":"2009","journal-title":"FASEB J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1053\/j.gastro.2010.06.069","article-title":"FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice.","volume":"139","author":"F Bohm","year":"2010","journal-title":"Gastroenterology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pep.2003.10.013","article-title":"Improved production of recombinant fibroblast growth factor 7 (FGF7\/KGF) from bacteria in high magnesium chloride.","volume":"33","author":"Y Luo","year":"2004","journal-title":"Protein Expr Purif"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/bc0601471","article-title":"Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge.","volume":"18","author":"S Balan","year":"2007","journal-title":"Bioconjug Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0076-6879(73)27039-8","article-title":"Automated Edman degradation: the protein sequenator.","volume":"27","author":"HD Niall","year":"1973","journal-title":"Methods Enzymol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1582-4934.2008.00506.x","article-title":"Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity.","volume":"14","author":"X Wu","year":"2010","journal-title":"J Cell Mol Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.toxlet.2007.03.001","article-title":"Enhanced protection of modified human acidic fibroblast growth factor with polyethylene glycol against ischemia\/reperfusion-induced retinal damage in rats.","volume":"170","author":"Z Huang","year":"2007","journal-title":"Toxicol Lett"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bbrc.1996.0001","article-title":"Continuous HGF supply from HGF-expressing fibroblasts transplanted into spleen prevents CCl4-induced acute liver injury in rats.","volume":"218","author":"T Kaido","year":"1996","journal-title":"Biochem Biophys Res Commun"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0036423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T22:55:21Z","timestamp":1642200921000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0036423"}},"subtitle":[],"editor":[{"given":"Aimin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,4]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0036423","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,4]]}}}